Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
BSX.PRA was delisted on the 31st of May, 2023.
43 hedge funds and large institutions have $1.08B invested in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 14 closing their positions.
7% more capital invested
Capital invested by funds: $1B → $1.08B (+$74.7M)
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
12% less funds holding
Funds holding: 49 → 43 (-6)
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$46.1M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.8M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$12.9M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$10.9M |
| 5 |
VanEck Associates
New York
|
+$10.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Camden Asset Management
Los Angeles,
California
|
-$37.3M |
| 2 |
Jane Street
New York
|
-$17M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$11.5M |
| 4 |
SC
Sculptor Capital
New York
|
-$7.88M |
| 5 |
MA
MUFG Americas
New York
|
-$5.69M |
BSX.PRA Hedge Fund Activity: Q3 2020 in Review
43 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) for Q3 2020, worth a combined $1.08B — up 7.5% from $1B a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of BSX.PRA and 8 opened new positions — a net loss of 6 holders — while 14 trimmed existing stakes and 13 added.
The largest buyer was Capital World Investors, adding an estimated $46.1M. The largest seller was Camden Asset Management, exiting entirely with an estimated $37.3M sold.
- 43 institutional investors held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) as of Q3 2020, down from 49 in Q2 2020.
- Funds reported $1.08B of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A stock for Q3 2020, up 7.5% quarter-over-quarter.
- 8 funds opened new Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A positions in Q3 2020 and 14 closed out, a net change of -6 holders.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A buyer in Q3 2020 was Capital World Investors, an estimated $46.1M added.
- The largest Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A seller in Q3 2020 was Camden Asset Management, an estimated $37.3M sold.
Based on aggregated 13F filings for Q3 2020.